These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20665754)

  • 21. Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate.
    Ohtaki N; Takahashi H; Kaneko K; Gomi Y; Ishikawa T; Higashi Y; Kurata T; Sata T; Kojima A
    Vaccine; 2010 Sep; 28(40):6588-96. PubMed ID: 20678586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays.
    Davis BS; Chang GJ; Cropp B; Roehrig JT; Martin DA; Mitchell CJ; Bowen R; Bunning ML
    J Virol; 2001 May; 75(9):4040-7. PubMed ID: 11287553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses.
    Siger L; Bowen R; Karaca K; Murray M; Jagannatha S; Echols B; Nordgren R; Minke JM
    Vet Ther; 2006; 7(3):249-56. PubMed ID: 17039448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII.
    Ramanathan MP; Kutzler MA; Kuo YC; Yan J; Liu H; Shah V; Bawa A; Selling B; Sardesai NY; Kim JJ; Weiner DB
    Vaccine; 2009 Jul; 27(32):4370-80. PubMed ID: 19497647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.
    Guy B; Guirakhoo F; Barban V; Higgs S; Monath TP; Lang J
    Vaccine; 2010 Jan; 28(3):632-49. PubMed ID: 19808029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case-control study of factors associated with development of clinical disease due to West Nile virus, Saskatchewan 2003.
    Epp T; Waldner C; Townsend HG
    Equine Vet J; 2007 Nov; 39(6):498-503. PubMed ID: 18065306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective efficacy of a recombinant subunit West Nile virus vaccine in domestic geese (Anser anser).
    Jarvi SI; Lieberman MM; Hofmeister E; Nerurkar VR; Wong T; Weeks-Levy C
    Vaccine; 2008 Oct; 26(42):5338-44. PubMed ID: 18723064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A recombinant envelope protein vaccine against West Nile virus.
    Ledizet M; Kar K; Foellmer HG; Wang T; Bushmich SL; Anderson JF; Fikrig E; Koski RA
    Vaccine; 2005 Jun; 23(30):3915-24. PubMed ID: 15917113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. West Nile Virus: is a vaccine needed?
    Martina BE; Koraka P; Osterhaus AD
    Curr Opin Investig Drugs; 2010 Feb; 11(2):139-46. PubMed ID: 20112163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The anamnestic serologic response to vaccination with a canarypox virus-vectored recombinant West Nile virus (WNV) vaccine in horses previously vaccinated with an inactivated WNV vaccine.
    Grosenbaugh DA; Backus CS; Karaca K; Minke JM; Nordgren RM
    Vet Ther; 2004; 5(4):251-7. PubMed ID: 15719324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus.
    Iglesias MC; Frenkiel MP; Mollier K; Souque P; Despres P; Charneau P
    J Gene Med; 2006 Mar; 8(3):265-74. PubMed ID: 16308885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The evolving means of protecting horses against West Nile infection through immunisation.
    Traub-Dargatz JL; Cordes T; Evans MB
    Equine Vet J; 2007 Nov; 39(6):484-5. PubMed ID: 18065303
    [No Abstract]   [Full Text] [Related]  

  • 33. Investigation of antigen specific lymphocyte responses in healthy horses vaccinated with an inactivated West Nile virus vaccine.
    Davis EG; Zhang Y; Tuttle J; Hankins K; Wilkerson M
    Vet Immunol Immunopathol; 2008 Dec; 126(3-4):293-301. PubMed ID: 18838173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An inactivated West Nile virus vaccine for domestic geese-efficacy study and a summary of 4 years of field application.
    Samina I; Khinich Y; Simanov M; Malkinson M
    Vaccine; 2005 Sep; 23(41):4955-8. PubMed ID: 16023273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes.
    Putnak R; Fuller J; VanderZanden L; Innis BL; Vaughn DW
    Am J Trop Med Hyg; 2003 Apr; 68(4):469-76. PubMed ID: 12875299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuated West Nile viruses bearing 3'SL and envelope gene substitution mutations.
    Yu L; Robert Putnak J; Pletnev AG; Markoff L
    Vaccine; 2008 Nov; 26(47):5981-8. PubMed ID: 18805457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. West Nile virus: recent trends in diagnosis and vaccine development.
    Dauphin G; Zientara S
    Vaccine; 2007 Jul; 25(30):5563-76. PubMed ID: 17292514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
    Gómez CE; Abaitua F; Rodríguez D; Esteban M
    Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Domestic goose as a model for West Nile virus vaccine efficacy.
    Sá E Silva M; Ellis A; Karaca K; Minke J; Nordgren R; Wu S; Swayne DE
    Vaccine; 2013 Feb; 31(7):1045-50. PubMed ID: 23277093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Twenty Years of Progress Toward West Nile Virus Vaccine Development.
    Kaiser JA; Barrett ADT
    Viruses; 2019 Sep; 11(9):. PubMed ID: 31491885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.